News

Lead investor Novartis Venture Fund, along with Technology Partners, made major contributions to this round of financing, which was also strongly supported by current investors Three Arch Partners,

In this capacity, Mr Meadows will be responsible for enterprise-wide supply chain operations including demand and supply planning; strategic sourcing and supplier management; procurement; materials and production planning;

Revenue recognition will begin in the second quarter of 2009 on a proportional basis as services are performed on each project. The backlog of the company was approximately

The vice president of science and technologychnology (VP of S&T) is a senior scientific and science-strategy position reporting directly to the company’s CEO. The VP of S&T will

The order for China Biologic’s Human Immunoglobulin for IV Injection 5g/100ml product will be delivered to the distributor over a nine-month period, commencing June 2009. The company believes

Most recently, Dr Becker served as senior director of small molecule development international at Biogen Idec, where he managed all chemistry, manufacturing and controls-related small molecule activities. Dr

Under the research program, Algonomics will collaborate with the research groups of Soren Buus (University of Copenhagen, Denmark) and Roberto Mallone (Inserm, France). This two year funding will

ICON has also appointed Gary Curtis as its new senior vice president of global clinical pharmacology. Dr Curtis will integrate the Omaha facility with ICON’s existing Phase I

According to Dr Reddy’s, Nexret is a next generation anti-acne formulation made from a non-porous microsphere technology. This unique technology minimizes irritation associated with drugs like Tretinoin and